Loading resource…

Erin D. Michos, M.D., M.H.S., John W. McEvoy, M.B., B.Ch., Roger S. Blumenthal, M.D.
The article discusses the historical context of cholesterol management, beginning with the Framingham Heart Study's identification of serum cholesterol as a risk factor for coronary heart disease. It reviews the evolution of guidelines, particularly those from the American College of Cardiology and American Heart Association, and emphasizes the role of lifestyle changes and pharmacotherapy in managing lipid levels. The review also details recent clinical trials and their implications for practice, particularly regarding LDL cholesterol and cardiovascular risk reduction.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology

PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology

OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology

CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology

The Athlete’s ECG
Same clinical topic · Cardiology

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology

Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology

Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology

INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology